MUFG Americas’s Editas Medicine EDIT Stock Holding History

MUFG Americas’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-823	Closed	-$20K	–	809
2019 Q1	$20K	Buy	+823	New	+$18.6K	﹤0.01%	651

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MUFG Americas's EDIT Position: Q2 2019 in Review

MUFG Americas sold out of Editas Medicine (EDIT) in Q2 2019, closing a stake of 823 shares — an estimated $20K sold.

MUFG Americas first reported a position in EDIT in Q1 2019 and held it in 1 quarter. The position peaked at $20K in Q1 2019. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2019.

MUFG Americas reported no remaining Editas Medicine position as of Q2 2019 after selling out during the quarter.
MUFG Americas sold 823 Editas Medicine shares in Q2 2019, an estimated $20K.
MUFG Americas first reported a position in Editas Medicine in Q1 2019 and held it in 1 quarter.
MUFG Americas's Editas Medicine position peaked at $20K in Q1 2019.
193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2019.

Based on MUFG Americas's 13F filing for Q2 2019, filed 9 Aug 2019.